Diabetes Care Devices | Market Insights | Asia Pacific | 2023
The Asia Pacific Diabetes care device market saw a short term impact of COVID-19 in 2020. Beyond the pandemic, moderate growth is anticipated over the forecast period, driven by favorable demographics and the adoption of advanced products—such as hybrid closed-loop insulin pumps—that command a premium price. However, the markets—particularly in China and India—continue to be limited by strong cost constraints that impede the uptake of premium-priced products.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for diabetes care devices in the Asia Pacific from 2019 through 2031.